MMJ Holdings, Rescheduling, and the Difference Between Process and Access
In 2023, Ganjactivist.com reported on MMJ International Holdings after the company secured a court order related to federal delays in its effort to develop FDA-approved cannabis-based medicine. At the time, the issue was clear. A company pursuing cannabinoid research and drug development was being slowed by federal inaction. For an industry that has spent decades…
